Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 68071-1671

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 68071-1671). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (33a5de83 A974 48a5 8ba6 4c1b97515615 01)

FDA Label Image

Image-2 (33a5de83 A974 48a5 8ba6 4c1b97515615 02)

Image-2 (33a5de83 A974 48a5 8ba6 4c1b97515615 02)
This is a chart displaying the concentration (in ng/mL) of Tramadol over time (in hours) for two different forms of the medication - extended-release tablets (200 mg q.d) and regular tablets (50 mg g6h). The chart shows the concentration decreasing over time for both forms.*
FDA Label Image

Image-3 (33a5de83 A974 48a5 8ba6 4c1b97515615 03)

Image-3 (33a5de83 A974 48a5 8ba6 4c1b97515615 03)
This is a chart showing the concentration of M1 in ng/mL over time in hours for two different types of tramadol hydrochloride medication: extended-release tablets (200 mg q.d.) and regular tablets (50 mg g6h).*
FDA Label Image

Image-4 (33a5de83 A974 48a5 8ba6 4c1b97515615 04)

Image-4 (33a5de83 A974 48a5 8ba6 4c1b97515615 04)
This document presents a chart showing the percentage of patients who achieved different levels of pain relief while taking Tramadol Hydrochloride Extended-Release Tablets in a study. The chart includes dosages of 100, 200, 300, and 400 mg, as well as a placebo. The results are based on an analysis of patients' response to pain, measured using the WOMAC Pain scale. The chart shows that higher doses of Tramadol were associated with higher percentages of patients achieving pain relief.*
FDA Label Image

Image-5 (33a5de83 A974 48a5 8ba6 4c1b97515615 05)

Image-5 (33a5de83 A974 48a5 8ba6 4c1b97515615 05)
This appears to be a chart or graph showing the results of a study (Study 015) related to Tramadol Hydrochloride Extended-Release Tablets and arthritis pain. The chart displays the percentage of patients who achieved various levels of pain reduction in comparison to a placebo group. However, without additional context or information, it is difficult to provide a more detailed description or analysis.*
FDA Label Image

Pdp (68071 1671 3)

Pdp (68071 1671 3)
This is a medication packaging from a pharmaceutical company named "Are Pharmaceuticals, Inc". The medication contained in the packaging is "Tramadol HC 100mg" and it is in the form of 30 E-R tablets. The lot number of the packaging is "000000" and the expiry date is "00-00". The product code is "R1593030". The manufacturer's label contains a full list of ingredients. The packaging includes a warning to keep it out of reach of children and to store it at a controlled temperature of 59-86°F. Contact number for FDA is also provided as 1-800-FDA-1088.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.